Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Definitive Healthcare Corp T.DH.R


Primary Symbol: DH

Definitive Healthcare Corp. is engaged in transforming data, analytics, and expertise into healthcare commercial intelligence. The Company’s solutions are designed to provide information on healthcare providers and their activities to help its customers optimize everything from product development to go-to-market planning and sales and marketing execution. Its software-as-a-service (SaaS) platform uses deep analytics and data science to help customers develop data-driven strategic decisions, such as finding new markets to enter, building comprehensive go-to-market strategies, accessing tactical information to help target the right decision makers and improving win rates with detailed contextual information. It transforms data into intelligence through artificial intelligence (AI) and machine learning (ML) algorithms that ingest, cleanse, link, and analyze the data to create new intelligence and analytics. All of its business is conducted through AIDH TopCo, LLC (Definitive OpCo).


NDAQ:DH - Post by User

Post by retiredcfon Feb 19, 2016 12:51pm
211 Views
Post# 24575479

CIBC

CIBC

DH Corp.
Q4 Preview: Focus On Fundtech Growth

What's The Event

DH will report Q4 results on Tuesday, February 23 after markets close and management will host a conference call on Wednesday, February 24 at 10:00 a.m. ET (dial-in 888-231-8191). We expect revenue of $426 mln. and adjusted EPS of $0.61 versus consensus of $430 mln. and $0.59, respectively. We estimate 29.9% adjusted EBITDA margins and a 8.3% FX-related revenue tailwind.

Implications

We believe investor focus will be on growth in GTBS (Fundtech) and expect management to provide Y/Y backlog growth (which we expect to be solid given commentary in Q3 that backlog was at record highs) and comments around organic growth (we believe the market is growing in the high single digits). With Q4 results, we will also be looking for an update on the base DH business and the outcome of the CSLP RFP. Key wins announced in the quarter include a contract with CooPACA for core processing and integrated enterprise suite and solid uptake in messaging solutions, up 25% Y/Y in 2015.

Looking into F2016, we see potential cross-sell opportunities with Canadian and major U.S. banks, geographic expansion into Europe, as well as traction in payments with modernization efforts and new fintech offerings. During the quarter, DH announced a partnership with Ripple to deliver innovative payment capabilities, including distributed ledger technology using blockchain.

We continue to like DH's positioning in the evolving fintech landscape, with the company using its stable Canadian operations to fund higher-growth opportunities in the U.S. In the near term, we expect cash will be used for debt repayment, but in the longer term we expect that DH will continue to consolidate and add additional products that further its cross-selling abilities.

Retain SO rating and $38 PT 


<< Previous
Bullboard Posts
Next >>